GE 医疗保健技术公司将 2024 财年每股收益预测更新至 4.20-4.35 美元，此前该公司 2023 年第四季度业绩有所改善，收入增长 5% 至 5 美元。 GE HealthCare Technologies updates FY2024 earnings forecast to $4.20-$4.35 EPS, following improved Q4 2023 results with 5% revenue growth to $5.

GE医疗保健技术公司（纳斯达克股票代码：GEHC）已将其2024财年盈利指引更新为每股收益4.200-4.350美元，并将2024财年每股收益指引更新为4.20-4.35美元。 GE HealthCare Technologies (NASDAQ:GEHC) has updated its FY 2024 earnings guidance to 4.200-4.350 EPS, and its FY 2024 guidance to $4.20-$4.35 EPS. 该公司公布 2023 年第四季度收入同比增长 5%，全年增长 7%。 The company reported a 5% year-over-year increase in Q4 2023 revenue, and a 7% increase for the full year. 2023 年第四季度，净利润率从上年的 11.2% 下降至 7.7%，全年利润率从 10.4% 下降至 8%。 In Q4 2023, net income margin declined to 7.7% from 11.2% the previous year, while full-year margin decreased to 8% from 10.4%.